Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

ViiV Healthcare synthesizes prodrugs of HIV maturation inhibitors

Nov. 15, 2019

Mologen announces the initiation of phase IIa TITAN combination trial

Nov. 8, 2019

Broad strategy for HIV bnAbs

Nov. 5, 2019

HIV replication inhibitors detailed in ViiV Healthcare patent

Nov. 4, 2019

Convertible CARs to the reservoir rescue?

Oct. 31, 2019

TaiMed Biologics discontinues development of TMB-607

Oct. 28, 2019

Reservoir grows when ART starts

Oct. 15, 2019

FDA approves Descovy for HIV-1 PrEP

Oct. 4, 2019

Chinese researchers describe new HIV antivirals

Oct. 1, 2019

European Commission approves Trogarzo for HIV-1

Sep. 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...